Vermont’s eugenics history demands public reckoning
By Steve May,
VT Digger
| 03. 13. 2017
Charles Murray, who spoke recently at Middlebury College, has reprised “the best of eugenics” to inform his lectures and writings including his book, “The Bell Curve.” Murray argues for the relative intelligence and suitability of ethnic groups to a host of workplace and societal activities based upon amongst other demographic drivers, “race.” Be clear, Dr. Murray’s work is nothing more than racial stereotyping dressed in cooked numbers and is designed to scramble the status quo. It’s the worst form of gutter politics masquerading as junk science.
A century ago, Americans led in what was then considered to be a promising area of scientific research. It had been used to bridge the gap between research and the conventions of society to explain why certain subsets of civilization were predisposed towards certain intellectual pursuits or physical ones. That area of scientific research has a name: eugenics. Eugenics involved attributing features about race and ethnicity to one’s biology or genetic profile. Most Americans and Vermonters are aware that this genetics-driven view of the world was at the core of Hitler’s political ideology. Biology...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Antonio Regalado, MIT Technology Review | 06.05.2025
Brian Armstrong, the billionaire CEO of the cryptocurrency exchange Coinbase, says he’s ready to fund a US startup focused on gene-editing human embryos. If he goes forward, it would be the first major commercial investment in one of medicine’s most...